Research Reports

“Despite the dynamic geopolitical and macroeconomic challenges... the Flotek team remains steadfast at the execution of our corporate strategy, driving transformation and delivering our 12th consecutive quarter of adjusted EBITDA improvement.” (CEO)
“Our DaaS-driven strategy ensures predictable recurring revenue and cash flow, delivering stability and long-term value.” (CEO)
“The XSPCT spectrometer became the first optical instrument to achieve the stringent reproducibility and repeatability requirements of GPA 2172 and API 14.5.” (CEO)
“We fully expect these assets to be a significant part of our 2026 results.” (CFO，关于PWRtek资产)
“We anticipate the Data Analytics segment will contribute to over half of the company's profitability in 2026.” (CEO)

Topic: Digital valuation deployment cadence and PWRtek power services update
Key points:
- Year-end goal of 25–35 units, with 200-plus sites expected in 2026; pilot phases complete, now commercial.
- Customer deployment decisions focus on maximum ROI (production wedge first, then custody transfer); no issue with manufacturing capacity—materials pre-bought, units being built.
- PWRtek: year-to-date $2.1 million revenue secured from non-PWRtek deals (excluding initial contract); 6 new customers in Q3 beyond ProFrac.
Mgmt stance: Bullish—steady quarterly unit growth expected; PWRtek sales cycle slower than frac monitoring but progress strong in Phase 1 (measurement).

Topic: PWRtek revenue projections, expansion strategy, and GPA 2172 regulatory update
Key points:
- PWRtek lease agreement: $27.4 million/year for first 5 years (fixed), then market rates; excludes $2 million non-PWRtek power services.
- Expansion steps: (1) real-time gas measurement (proven—5 new customers in Q3), (2) control (e.g., ESD trailers, smart filtration), (3) distribution trailers—built 4 ESD trailers, POs for distribution trailers in Q4.
- GPA 2172 (API 14.5) compliance achieved—optical spectroscopy (XSPCT) meets GC reproducibility/repeatability; key for midstream adoption.
Mgmt stance: Bullish—aggressive capital delivery plan for 2026; regulatory hurdle cleared enables broader custody transfer deployment.

Topic: International chemicals growth tied to Middle East customer (Aramco contract)
Key points:
- International revenues year-to-date up 122% (driven by initial work); mega tender for Aramco completed, with customer securing 100% of hydraulic fracturing scope.
- Expect business pick-up in back half of Q4 and heavily in 2026—no specific guidance on expectations.
Mgmt stance: Bullish—positioning for significant growth in Middle East; very positive outlook.

Topic: Efficiency gains from GPA 2172 and chemistry business outlook
Key points:
- Post-GPA 2172: custody transfer measurement every ~5 seconds (vs. 3–6 months manual); resolves 3%–5% sampling bias; reduces overall CapEx and maintenance by ~50%.
- Chemistry: domestic growth driven by efficiency focus (real-time water quality, concentrate pumping—7 totes vs. 8–10 ISOs); international (Middle East, Latin America, Asia Pac) to be material.
- U.S. land: flat water utilization; 90% of spend for maintenance; underinvestment may trigger shift; Flotek’s data-driven solutions positioned to bridge Tier 1/Tier 2 gap.
Mgmt stance: Bullish—plenty of room to grow chemistry revenues even with flat fleet counts; long-term positive inflection point expected.

Topic: PWRtek unit expansion targets, tax rate, and ProFrac chemistry shortfall
Key points:
- PWRtek: goal to double paired fleet size by end of 2026 (no specific unit guidance); base contract is $27.4 million—potential to double that in 2026.
- GAAP tax rate: normalizing to ~20% after $12.6 million deferred tax credit release in Q3.
- ProFrac chemistry shortfall: $7.2 million deferred liability on balance sheet (loan against 2025 shortfall penalty); to be offset against PWRtek acquisition consideration in Q1 2026.
- Chemistry sales to ProFrac expected to improve in Q4 due to increased work; shortfall driven by fleet shift from Permian to gas-rich basins.
Mgmt stance: Neutral/bullish—reasonable goal to double PWRtek fleet; tax rate normalized; chemistry shortfall expected to improve as fleet mix changes.

Topic: Data analytics gross margin normalization, capacity, working capital, and financing headroom
Key points:
- This year’s PWRtek agreement generates ~$16M revenue at 89%–90% gross margins; next year that revenue jumps by 70%, which management expects will push weighted-average gross margins above 70%, possibly closer to 80%.
- No near-term resource or cost constraints for post-sale support; measurement devices (Verax/XSPCT) can be turned in days, large equipment in ≤5 weeks; capital outlay planning is on a 36–60 month horizon for facility capacity, not personnel/equipment.
- International customers (Middle East) pay 20–25 days slower than North American land customers, adding to DSO; if Middle East business ramps significantly, working capital will be consumed in first half of 2026, stabilizing by mid-Q2.
- Current liquidity: ~$15M available under ABL, very low leverage, potential cash payment from OSP in 1Q (net of $7M offset could be $20M–$25M), plus optionality in debt or equity markets.
Mgmt stance: Bullish – high-margin PWRtek growth is expected to lift overall margins significantly; existing capacity and quick build times support demand; ample liquidity and financing options to manage working capital needs from international expansion.